A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus.
CRISPR-Cas12a biosensing is hindered by insufficient sensitivity that necessitates pre-amplification, as well as the limited ability to directly detect non-nucleic-acid targets. Herein, we developed a CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA (e-crRNA), enabling Mn2+-responsive control ov...